Protection From AI-Driven Payer Denials

PROTECTION FROM AI-DRIVEN PAYER DENIALS THROUGH IMPROVED CLINICAL DOCUMENTATION

Leveraging Established Medical Necessity & Risk Concepts for Sustainable Revenue Integrity & Patient Care

INTRODUCTION

The healthcare reimbursement landscape is rapidly evolving as payers increasingly adopt artificial intelligence (AI) and automated algorithms to evaluate medical necessity, inpatient (IP) status appropriateness, and claims eligibility. While these technologies promise efficiency and cost containment for insurers, they also introduce substantial challenges for hospitals, physicians, and clinical documentation integrity (CDI) teams. AI-driven payer denials have emerged as a major threat to hospital revenue cycles, physician autonomy, and timely patient care. Retrospective denials based on automated documentation review are becoming more frequent, particularly involving short-stay IP admissions, observation-to-IP conversions, and two-midnight rule compliance.

Recent regulatory updates from the Centers for Medicare & Medicaid Services (CMS) attempt to limit inappropriate retrospective denials. Effective January 1, 2026, Medicare Advantage Organizations (MAOs) are prohibited from denying short-stay IP admissions if the physician’s admission decision was reasonably based on the information available at the time of admission, and the medical record supports an expectation of medically necessary care spanning at least two midnights.¹ Despite these protections, hospitals remain vulnerable because payer algorithms increasingly scrutinize documentation language that hunts for and identifies vague phrasing, contradictions, or insufficient specificity as grounds for denials.

In this environment, high-quality clinical documentation has become one of the most important defensive strategies available to healthcare organizations. One approach to consider when documenting IP medical necessity is the SICK mnemonic. This practical documentation framework is organized around four clinically relevant domains: Severity of illness, Intensity of care, Comorbidities, and Known risk of morbidity and mortality. The SICK framework incorporates established concepts relevant to medical necessity and clinical risk. AppriseMD believes this cognitive aid helps clinicians clearly articulate the patient’s acuity, required hospital-level services, complicating conditions, and anticipated clinical risk. This model helps build the documentation foundation for safeguarding patient care and protecting the financial integrity of healthcare organizations.

This paper examines the rise of AI-driven payer denials, the financial and operational risks posed to healthcare systems, the regulatory response from CMS, and the opportunities healthcare organizations have to improve documentation practices using the SICK framework. Additionally, it explores how CDI programs, physician advisors, and denial management teams can proactively protect hospitals from automated denials while simultaneously improving patient care quality and reimbursement integrity.

THE RISE OF AI-DRIVEN PAYER DENIALS
AI and natural language processing technologies are transforming payer operations. Insurance companies now utilize AI systems capable of rapidly scanning medical records for patterns associated with noncompliance, insufficient documentation, or perceived lack of medical necessity. These systems can process thousands of claims simultaneously and issue denials at a speed far beyond traditional human review processes.

AI-driven denials are particularly prevalent in cases involving:

• Short IP stays.
• Observation-to-IP conversions.
• Two-Midnight rule compliance.

These algorithms are designed to identify documentation inconsistencies, vague terminology, and perceived low-acuity clinical presentations. Even when physicians make clinically appropriate admission decisions, insufficiently detailed documentation may trigger automated denials. This provides an opportunity for the payers to deny many claims at one time. For commercial and private plans, there is no federal mandate that addresses AI-driven batch denials, but some states have passed legislation prohibiting AI-driven medical necessity denials without human oversight. Legitimate claims can also be denied through AI hallucinations, where AI misreads information to produce misleading or false data even though it is presented as fact. AI models can also be sycophantic, by adapting to payer expectations and thus denying large numbers of claims in efforts to please the health insurance companies. Additionally, these models cannot determine provider thought processes, so they rely on the medical record and the strength of the documentation.

AI-driven denials are particularly prevalent in cases involving:

• Short IP stays.
• Observation-to-IP conversions.
• Two-Midnight rule compliance.
• Medical necessity determinations.
• Level-of-care (LOC) disputes.
• Day-by-day IP necessity reviews.

These algorithms are designed to identify documentation inconsistencies, vague terminology, and perceived low-acuity clinical presentations. Even when physicians make clinically appropriate admission decisions, insufficiently detailed documentation may trigger automated denials.

FINANCIAL IMPACT OF PAYER DENIALS

The financial consequences of payer denials are substantial. According to research published in Health Affairs² MA plans denied 17% of all initial claims in 2019. Of those denied claims, 57% were eventually overturned through appeals, but providers still experienced a 7% net reduction in MA revenue.

This data demonstrates several critical realities:

• Many denials are inappropriate and reversible.
• Appeals are resource-intensive and costly.
• Some organizations lack sufficient denial management infrastructure to
• overturn denials effectively.

High-dollar diagnosis-related groups (DRGs) are especially vulnerable. According to an article published by Health Affairs, the top 10% of IP DRGs by spend experienced denial rates exceeding 18%, compared to less than 9% among lower-spend DRGs.² These findings reveal that payers strategically focus on high-cost admissions where denial losses are higher for hospitals.

AI-driven denials therefore create both operational and financial strain, in the form of:

• Increased administrative burden.
• Delayed reimbursement.
• Higher labor costs for appeals.
• Physician frustration.
• CDI workload escalation.
• Patient dissatisfaction.
• Cash flow instability.

Hospitals that fail to address documentation vulnerabilities may face escalating denial rates and worsening revenue cycle performance. Reduced financial stability has the potential to lead to poor quality outcomes.

CMS REGULATORY CHANGES & IMPLICATIONS

The CMS Calendar Year 2026¹ rule represents an important advancement in protecting hospitals from retrospective payer abuse. Under the updated policy, MAOs cannot deny IP admissions using information that becomes available after the admission decision if the physician reasonably expected a two-midnight stay based on the initial presentation. This policy reinforces the clinical judgment of physicians and realigns medical necessity determinations around real-time decision-making. However, CMS also emphasizes the importance of documentation quality. Physicians must clearly explain why they expect the patient to require at least two midnights of medically necessary hospital-level care.

Recommended language includes: “Given this patient’s severity of illness, risk for complications, and need for intensive services such as telemetry, IV medications, frequent neurological checks, and serial laboratory monitoring, I expect the patient will require at least two midnights of medically necessary hospital-level care.”

This requirement creates an opportunity for hospitals to standardize documentation practices and improve provider education, resulting in a higher probability of reimbursement. Organizations that proactively align documentation with CMS expectations will be better positioned to defend against automated denials to ensure payment for services provided.

THE IMPORTANCE OF CDI

CDI programs are pivotal in denial prevention and are becoming increasingly important in payer provider alignment. Historically, CDI efforts focused heavily on coding specificity and reimbursement optimization. Today, however, CDI responsibilities have expanded dramatically and are focused on DRG accuracy, warranting a refocus.

CDI responsibilities include:

• Medical necessity support.
• IP status justification.
• Two-midnight compliance.
• Denial prevention strategies.
• Physician documentation education.
• AI-aware documentation practices.

Modern CDI programs must recognize that payer algorithms interpret records differently than human clinicians. AI systems may flag phrases that appear benign to physicians but suggest low acuity from a utilization management perspective.

Phrases that may significantly weaken IP status justification:

• “Patient stable.”
• “Awaiting tests.”
• “Conservative management.”
• “Symptoms improved.”
• “Comfortable at rest.”

These statements are often labeled “denial fodder” because they imply the patient could potentially be managed at a lower LOC. Therefore, documentation must be explicit, clinically detailed, internally consistent, and aligned with payer expectations without sacrificing clinical accuracy.

THE SICK FRAMEWORK AS A DEFENSIVE DOCUMENTATION STRATEGY

One effective approach to documenting the clinical factors relevant to IP medical necessity and payer review incorporates the SICK framework.

SEVERITY OF ILLNESS
Severity of illness refers to the acuity and physiological instability of the patient’s condition. This is also one of the metrics that CMS uses when setting payment rates for IP stays³ and documentation should clearly communicate why the patient is acutely ill and unable to be safely managed at a lower LOC.

Strong documentation examples include:

• “Persistent vital sign abnormalities despite treatment.”
• “Significant physiologic instability not expected to resolve within the observation timeframe.”
• “Refractory symptoms despite initial management.”
• “Rapid clinical deterioration.”
• “Failed outpatient treatment.”

These statements establish clinical seriousness and justify IP admission. In contrast, vague statements such as “mild exacerbation” or “stable on arrival” may undermine medical necessity.

INTENSITY OF CARE

Intensity of care describes the level of monitoring, interventions, and hospital resources required. CMS establishes this, combined with severity of illness, as complex medical factors that medical administrative contractors consider when evaluating whether physicians were reasonable in establishing the expectation
that the patient required hospital services for two or more midnights. ⁴

Effective documentation should specify:

• Frequency of monitoring.
• Intravenous therapies.
• High-risk medications.
• Specialized nursing care.
• Continuous monitoring requirements.
• Complex multidisciplinary interventions.

Examples include:

• “Requires ongoing IV therapy and serial lab monitoring beyond 24–48 hours.”
• “Neurological checks every 1 hour (Q1H) to 2 hours (Q2H) are medically necessary.”
• “Continuous cardiac monitoring required.”
• “Initiation and titration of high-risk medications.”

These details demonstrate that the patient requires hospital-level services that cannot safely occur in observation or outpatient settings.

COMORBIDITIES

Most IP stays are complicated by one or more comorbidities that affect patient care because they require clinical evaluation or therapeutic treatment, extend the length of stay, or increase nursing care and/or monitoring.⁵ With comorbidities significantly increasing patient complexity and risk, clinical documentation should explain how underlying conditions complicate treatment and recovery.

Important phrases include:

• “Underlying comorbid conditions increase complexity of care.”
• “Coexisting conditions elevate risk of poor outcomes.”
• “Baseline functional impairment complicates expected recovery."

For example, pneumonia in an otherwise healthy young patient differs dramatically from pneumonia in an elderly patient with heart failure, chronic kidney disease, and diabetes. The latter requires more intensive monitoring and carries a greater risk of
deterioration.

AI systems evaluate whether providers explicitly connect comorbidities to clinical risk. Merely listing diagnoses is insufficient.

KNOWN RISK OF MORBIDITY AND MORTALITY

Morbidity and mortality are vital documentation components that help healthcare teams address anticipated risk if IP care is not provided.

Strong documentation includes:

• “Clinical course poses high risk for morbidity/mortality unless managed IP.”
• “Disposition to lower LOC inconsistent with best-practice risk stratification.”
• “Requires IP setting to avoid complications associated with disease progression.”

This section is critical because it explains why discharging or downgrading the patient would be unsafe.

ELIMINATING “DENIAL FODDER”

One of the greatest opportunities for improving documentation involves eliminating language commonly targeted by payer algorithms.

The SICK documentation presentation identifies several problematic phrases requiring clarification, including:

• “Patient stable.”
• “Awaiting test results.”
• “Supportive care.”
• “Conservative management.”
• “Appears comfortable.”
• “Plan for discharge tomorrow.”

While these phrases may be clinically accurate in isolation, they often fail to support IP-level medical necessity.

Instead, providers should use objective, clinically meaningful terminology that reflects:

• Persistent instability.
• Ongoing risk.
• Intensive interventions.
• Failure of outpatient management.
• Need for close monitoring.

For example: Instead of “Awaiting MRI results,” use: “Persistent focal neurologic deficits requiring serial neurochecks and emergent MRI evaluation due to concern for evolving cerebrovascular event.”

This alternative clearly communicates severity, risk, and intensity of care.

OBSERVATION-TO-IP CONVERSIONS
Observation-to-IP conversions represent a major area of payer scrutiny. AI systems frequently review these cases for evidence supporting escalation of care.

Documentation should explain:

• Clinical deterioration.
• New abnormal findings.
• Increased intensity of services.
• Failure of observation-level treatment.
• Continued need for hospital-level care beyond two midnights.

CMS guidance emphasizes that the progress note on the day of conversion must clearly articulate why IP care is now medically necessary.⁶ Weak documentation, such as “needs additional IV antibiotics,” is often insufficient.

Stronger documentation would state:

“Persistent sepsis physiology with worsening leukocytosis, ongoing hypotension, and continued need for intravenous broad-spectrum antibiotics, telemetry monitoring, and serial laboratory assessment.”

Specificity is essential for preventing automated denials.

THE ROLE OF PHYSICIAN ADVISORS AND DENIAL MANAGEMENT TEAMS

Physician advisors and denial management teams are increasingly critical in combating payer denials. Their responsibilities include conducting peer-to-peer (P2P) reviews, educating physicians, tracking denial trends, identifying payer behavior patterns, collaborating with CDI specialists, and escalating systemic denial issues to leadership. AppriseMD can help with denials based on weak clinical
documentation during P2P calls to get those overturned based on clinical discussions with the payer medical directors.

Hospitals should also maintain robust analytics programs to identify:

• Frequently denied DRGs.
• High-risk payers.
• Common documentation deficiencies.
• Trends in AI-generated denials.

Sharing this data across departments—including compliance, finance, patient experience, and contracting teams—allows organizations to develop coordinated responses. Organizations that aggressively appeal denials frequently recover substantial revenue while also discouraging inappropriate payer practices. AppriseMD can help overturn denials based on weak or vague clinical documentation.

PREPARING FOR THE FUTURE OF AI IN HEALTHCARE REIMBURSEMENT

AI will continue expanding throughout healthcare reimbursement systems. CMS itself has begun incorporating AI into medical claim review processes through initiatives such as the Wasteful and Inappropriate Service Reduction Model (WISeR)⁷. Consequently, providers must adapt documentation practices for both human and machine interpretation.

Future-ready documentation strategies should include:

• Standardized IP medical necessity language.
• Provider education on AI-driven denial risks.
• Real-time CDI intervention.
• Templates incorporating SICK principles.
• Continuous denial analytics monitoring.
• Interdisciplinary collaboration between CDI, utilization review, and physician advisors.

Healthcare organizations must recognize that documentation is no longer solely a clinical communication tool—it is also a legal, financial, and algorithmic defense mechanism.

CONCLUSION

AI-driven payer denials represent one of the most significant operational and financial threats facing healthcare organizations today. Automated claim review systems increasingly scrutinize IP documentation for medical necessity justification, particularly in short-stay admissions and observation-to-IP conversions. Although CMS has implemented new protections limiting retrospective denials based on post-admission information, hospitals remain vulnerable if documentation lacks specificity, consistency, and explicit justification for IP care. This is where AppriseMD comes in. AppriseMD physician advisors can address weak clinical documentation during P2P discussions with the payer medical directors to overturn these denials.

The SICK framework provides an effective methodology for strengthening clinical documentation by emphasizing the severity of illness, intensity of care, comorbidities, and known risk of morbidity and mortality. When consistently applied, the SICK framework can help clinicians more clearly document the
factors supporting medical necessity, which may strengthen the record during payer review. This is another area where AppriseMD comes in. During second-level reviews, AppriseMD physician advisors engage with attending physicians during P2P calls to ensure that the medical record accurately depicts the patient’s current admission status. These physician-to-physician calls can fill the gaps in clinical documentation, ensuring that the medical record is accurately reflected during payer review.

Healthcare organizations must proactively respond to the evolving payer landscape by investing in CDI education, denial prevention strategies, physician advisor programs, and data analytics. Documentation should be composed with the expectation that both human reviewers and AI systems will interpret the medical record. Clear, objective, and clinically precise language is essential.

Ultimately, the goal is not simply to avoid denials but to ensure that the medical record accurately reflects the complexity of patient care, supports appropriate reimbursement, and protects patients from unsafe downgrades in care. Organizations that commit to strong documentation practices now will be better
equipped to navigate the increasingly automated future of healthcare reimbursement.

SOURCES

1. Centers for Medicare and Medicaid Services, “Medicare and Medicaid Programs; Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly,” April 15, 2025.
2. Vabson, Boris, Hicks, Andrew L., and Chernew, Michael E., “Medicare Advantage Denies 17 Percent Of Initial Claims; Most Denials Are Reversed, But Provider Payouts Dip 7 Percent,” Health Affairs. June 2, 2025.
3. Centers for Medicare and Medicaid Services, “Fact Sheet: Two-Midnight Rule,” October 30, 2015.
4. Centers for Medicare and Medicaid Services, “Reviewing Hospital Claims for Patient Status: Admissions On or After October 1, 2013,” January 31, 2014.
5. Owens, Pamela L., Liang, Lan, Barrett, Marguerite L., et al., “Comorbidities Associated With Adult Inpatient Stays, 2019,” Healthcare Costs and Utilization Project (HCUP) Statistical Briefs: Agency for Healthcare Research and Quality (US). December 15, 2022.
6. Centers for Medicare and Medicaid Services, “Hospital Patient Status Review Frequently Asked Questions.” March 2, 2026.
7. Centers for Medicare and Medicaid Services, “Model Overview Factsheet: Wasteful and Inappropriate Service Reduction (WISeR) Model.” June 22, 2025.

ADDITIONAL SOURCES:

• American Hospital Association, “Payer Denial Tactics — How to Confront a $20 Billion Problem,” April 2, 2024.
• Alumran, Arwa, et. al., “Optimizing Health Insurance Claims Processing: The Role of Clinical Documentation Improvement (CDI),” National Library of Medicine. April 11, 2026.
• Kansas Legislative Research Department, “Briefing Book 2026: Artificial Intelligence Use in Health Insurance,” March 2, 2026.
• Tracy, Alexander, et. al., “The case for an international severity of illness scoring system,” National Library of Medicine. February 28, 2025.
• U.S. Department of Health and Human Services, “Medicare Advantage Organizations Overturned Nearly All Appealed Prior Authorization Denials for Skilled Nursing Facility Admission, Raising Concerns About Initial Denials,” June 8, 2026.
• University of Illinois, Urbana-Champaign, “Introduction to Generative AI: Hallucinations,” April 14, 2026.
• Valderas, Jose M., et. al., “Defining Comorbidity: Implications for Understanding Health and Health Services,” Annuals of Family Medicine. July 7, 2009.
• Winecoff, Amy, “Artificial Sweeteners: The Dangers of Sycophantic AI,” TechPolicy.Press. May 14, 2025.